GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (FRA:E4NA) » Definitions » Payments on Behalf of Employees

Arovella Therapeutics (FRA:E4NA) Payments on Behalf of Employees : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arovella Therapeutics Payments on Behalf of Employees?

Arovella Therapeutics's Payments on Behalf of Employees for the six months ended in Jun. 2024 was €0.00 Mil.

Arovella Therapeutics's Payments on Behalf of Employees for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.


Arovella Therapeutics Payments on Behalf of Employees Historical Data

The historical data trend for Arovella Therapeutics's Payments on Behalf of Employees can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arovella Therapeutics Payments on Behalf of Employees Chart

Arovella Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Payments on Behalf of Employees
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Arovella Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Payments on Behalf of Employees Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Arovella Therapeutics Payments on Behalf of Employees Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Payments on Behalf of Employees represents cash paid in a form of salaries or other benefits to employees of the company, in the direct cash flow method.

Payments on Behalf of Employees for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arovella Therapeutics Payments on Behalf of Employees Related Terms

Thank you for viewing the detailed overview of Arovella Therapeutics's Payments on Behalf of Employees provided by GuruFocus.com. Please click on the following links to see related term pages.


Arovella Therapeutics Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton, WA, AUS, 3053
Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.

Arovella Therapeutics Headlines

No Headlines